Clover Health Investments, Corp.
CLOV
$3.10
-$0.07-2.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 33.71% | 8.86% | 7.23% | 9.51% | 7.16% |
| Total Other Revenue | 14.62% | 36.91% | 75.22% | 10.51% | -3.53% |
| Total Revenue | 33.45% | 9.28% | 8.29% | 9.53% | 7.00% |
| Cost of Revenue | 33.29% | -2.69% | 5.93% | 1.67% | -3.50% |
| Gross Profit | 33.95% | 60.30% | 16.26% | 33.20% | 65.86% |
| SG&A Expenses | 5.69% | 6.62% | -11.22% | -4.06% | -18.03% |
| Depreciation & Amortization | 46.54% | -48.96% | -39.14% | -66.97% | 13.98% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.55% | 0.03% | 0.70% | -0.23% | -8.07% |
| Operating Income | 94.42% | 57.07% | 71.14% | 131.74% | 70.71% |
| Income Before Tax | 94.50% | 68.38% | 73.87% | 124.82% | 70.93% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 94.50% | 68.38% | 73.87% | 124.82% | 70.93% |
| Earnings from Discontinued Operations | -- | 75.82% | 95.29% | 217.33% | -43.60% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 93.35% | 68.65% | 77.92% | 125.71% | 73.60% |
| EBIT | 94.42% | 57.07% | 71.14% | 131.74% | 70.71% |
| EBITDA | 96.41% | 57.18% | 71.70% | 134.54% | 71.01% |
| EPS Basic | 93.40% | 69.31% | 78.33% | 125.29% | 74.01% |
| Normalized Basic EPS | 94.54% | 58.00% | 71.67% | 131.11% | 71.19% |
| EPS Diluted | 93.40% | 68.83% | 75.90% | 117.47% | 74.01% |
| Normalized Diluted EPS | 94.54% | 58.00% | 71.67% | 130.48% | 71.19% |
| Average Basic Shares Outstanding | 2.20% | 2.13% | 1.96% | 1.74% | 1.58% |
| Average Diluted Shares Outstanding | 2.20% | 2.13% | 1.96% | 3.34% | 1.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |